NORD gratefully acknowledges Charlotte Ockeloen, Clinical Geneticist and Clinical pharmacologist in training, Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands, for her assistance in updating this report.
Children with KBG syndrome may display characteristic physical abnormalities of the head and face (craniofacial dysmorphism). The shape of the skull can be abnormal, with a flat back of the head (brachycephaly). Characteristic facial features may include eyes that appear widely spaced apart (hypertelorism) or crossed (strabismus); wide, bushy eyebrows; thin, bow-shaped lips; and/or a triangularly-shaped face. There is typically a full tip of the nose with upturned nostrils. Characteristic features may also include abnormally large teeth in comparison to the jaws (macrodontia). Macrodontia is particularly common in KBG syndrome and often affects the two upper middle teeth (upper central incisors). Affected individuals may also have jagged, crowded, or misaligned teeth and/or unusually short, flattened, supporting bones or sockets of the jaw (mandible) that house the teeth (alveolar ridges). Microcephaly has been described in some children. Microcephaly is a condition in which the circumference of the head is smaller than would be otherwise expected based on age and gender. However, most children with KBG syndrome have a normal head size.
A child with KBG syndrome may also be of short stature, have speech and hearing impairments, and/or have mild to moderate levels of intellectual disability. Children with intellectual disability may experience delays in reaching developmental milestones. Some children will only experience mild learning disabilities. Other children will not have intellectual disability and have no issues with learning or thinking that are related to KBG syndrome. Children experience recurrent ear infections (otitis media), which may contribute to hearing loss.
Some children experience behavioral anomalies including attention deficit hyperactivity disorder (ADHD), temper tantrums, and compulsive or aggressive behavior. Autism spectrum disorder can also be present in children with KBG syndrome. .
Affected children may have delayed bone age, which means that a child’s bones mature at a slower rate. This may contribute to a variety of skeletal malformations including abnormal bone development (skeletal dysplasia) such as malformations of the bones of the spine (vertebrae); the shortened middle portion of the thigh bones (femoral neck); abnormally developed hip bones (hip dysplasia); and/or shortened, hollow finger bones (metacarpals).
In some children, associated features may include a sunken, pushed-in appearance of the chest (pectus excavatum or “funnel chest”); a single deep crease across the palms of the hands (simian crease); certain bones of the hands may be short (short tubular bones of the hands), pinkies that are unusually short (brachydactyly) and/or that may be stuck in a bent position (clinodactyly).
Less commonly, additional findings have been reported in some children including congenital heart defects, seizures, defects affecting the roof of the mouth (palate), webbing or fusion (syndactyly) of the middle toes, and a webbed, short neck. Some males may have undescended testicles (cryptorchidism). Some infants have feeding difficulties.
Delayed closure of the ‘soft spots’ or fontanelles has also been reported. An infant’s skull has seven bones and several joints called sutures. Sutures are made of tough, elastic fibrous tissue and separate the bones from one another. Sutures meet up (intersect) at two spots on the skull called fontanelles, which are better known as an infant’s “soft spots”. The seven bones of an infant’s skull normally do not fuse together until around age two or later. The sutures normally remain flexible until this point. In some infants, this fusion is delayed.
KBG syndrome is caused by either an alteration (mutation) in the ANKRD11 gene, or a loss of genetic material from chromosome 16q that includes the ANKRD11 gene. Genes provide instructions for creating proteins that play a critical role in many functions of the body. When a mutation of a gene occurs, the protein product may be faulty, inefficient, or absent. Depending upon the functions of the particular protein, this can affect many organ systems of the body.
The ANKRD11 gene contains instructions for creating a protein that is active in nerve cells (neurons). The exact role of this protein is not fully understood. When the ANKRD11 is altered or missing, individuals cannot produce enough functional copies of this protein. More research is necessary to determine how low levels of the protein product of the ANKRD11 gene causes the symptoms of KBG syndrome.
KBG syndrome is inherited as an autosomal dominant trait. Most genetic diseases are determined by the status of the two copies of a gene, one received from the father and one from the mother. Dominant genetic disorders occur when only a single copy of an altered or missing gene is necessary to cause a particular disease. The affected gene can be inherited from either parent or can be the result of a new, spontaneous mutation (gene change) in the affected individual. This may be referred to as a “de novo” change. The risk of passing the altered gene or missing chromosome segment from an affected parent to an offspring is 50% for each pregnancy. The risk is the same for males and females.
KBG syndrome is a rare disorder that affects males and females. Currently, more than 150 cases have been reported in the medical literature. The disorder can go undiagnosed or misdiagnosed, making it difficult to determining the true frequency of KBG syndrome in the general population.
A diagnosis of KBG syndrome may be suspected after a thorough clinical evaluation, a detailed patient and family history, and the identification of characteristic physical findings. The diagnosis can also be made by gene panel analysis or next generation sequencing techniques, where multiple genetic causes of for example intellectual disability are investigated at the same time.
Treatment is directed toward the specific symptoms that are apparent in each individual. Treatment may require the coordinated efforts of a team of specialists. Pediatricians, orthopedists, orthopedic surgeons, neurologists, physical therapists, speech therapists, orthodontists, and other healthcare professionals may need to systematically and comprehensively plan an affected child’s treatment. Genetic counseling may be of benefit for affected individuals and their families. Psychosocial support for the entire family may be beneficial as well.
Orthopedic surgery may be particularly helpful to correct hip and spine abnormalities of affected individuals. Hearing aids, speech therapy, and comprehensive dental care may also be beneficial.
Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.
For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:
Toll-free: (800) 411-1222
TTY: (866) 411-1010
For information about clinical trials sponsored by private sources, contact:
For more information about clinical trials conducted in Europe, contact: https://www.clinicaltrialsregister.eu/
Some children with KBG syndrome have been treated with growth hormone therapy. Initial results have been promising in helping children who are experiencing delays or diminished growth. More research is necessary to determine the long-term safety and effectiveness of growth hormone therapy in children with KBG syndrome.
Dowling PA, Fleming P, Gorlin RJ. KBG Syndrome. In: NORD Guide to Rare Disorders. Lippincott Williams & Wilkins. Philadelphia, PA. 2003:210.
Gorlin RJ, et al., eds. Syndromes of the Head and Neck, 3rd ed. New York, NY: Oxford University Press; 1990:840-1.
Low K, Ashraf T, Canham N, et al. Clinical and genetic aspects of KBG syndrome. Am J Med Genet A. 2016 [Epub ahead of print]. http://onlinelibrary.wiley.com/doi/10.1002/ajmg.a.37842/full
Goldenberg A, Riccardi F, Tessier A, et al. Clinical and molecular findings in 39 patients with KBG syndrome caused by deletion or mutation of ANKRD11. Am J Med Genet A. 2016; [Epub ahead of print]. https://www.ncbi.nlm.nih.gov/pubmed/27605097
Ockeloen CW, Willemsen MH, de Munnik S, et al. Further delineation of the KBG syndrome caused by ANKRD11 aberrations. Eur J Hum Genet. 2015;23:1270. http://www.ncbi.nlm.nih.gov/pubmed/26269249
Reynaert N, Ockeloen CW, Savedahl L, et al. Short stature in KBG syndrome: first responses to growth hormone treatment. Horm Res Paediatr. 2015;83:361-364. http://www.ncbi.nlm.nih.gov/pubmed/25833229
Sirmaci A, Spiliopoulos M, Brancati F, et al. Mutations in ANKRD11 cause KBG syndrome, characterized by intellectual disability, skeletal malformations, and macrodontia. Am J Hum Genet. 2011;89:289-294. http://www.ncbi.nlm.nih.gov/pubmed/21782149
Almandey AH, Anthonappa RP, King NM, Fung CW. KBG syndrome: clinical features and specific dental findings. Pediatr Dent. 2010;32:439-444. http://www.ncbi.nlm.nih.gov/pubmed/21070713
Brancati F, Sarkozy A, Dallapiccola B. KBG syndrome. Orphanet J Rare Dis. 2006;1:50. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1764006/
Tekin M, Kavaz A, Berberoglu M, et al. The KBG syndrome: confirmation of autosomal dominant inheritance and further delineation of the phenotype. Am J Med Genet A. 2004;130A:284-287. http://www.ncbi.nlm.nih.gov/pubmed/15378538
Dowling PA, Fleming P, Gorlin RG, et al. The KBG syndrome, characteristic dental findings: a case report. Int J Paediatr Dent. 2001;11:131-34. http://www.ncbi.nlm.nih.gov/pubmed/11310136
Sacharow S, Li D, Fan Ys, Tekin M. Familial 16q24.3 microdeletion involving ANKRD11 causes a KBG-like syndrome. Am J Med Genet A. 2012;158A:547-552. http://www.ncbi.nlm.nih.gov/pubmed/22307766
Mathieu M, Helou M, Morin G, et al. The KBG syndrome: an additional sporadic case. Genet Couns. 2000;11:33-35. http://www.ncbi.nlm.nih.gov/pubmed/10756425
Soekarman D, Volcke P, Fryns JP. The KBG syndrome: follow-up data on three affected brothers. Clin Genet. 1994;46:283-86. http://www.ncbi.nlm.nih.gov/pubmed/7834892
Zollarion M, Battaglia A, D’Avanzo MG, et al. Six additional cases of the KBG syndrome: clinical reports and outline of the diagnostic criteria. Am J Med Genet. 1994;52:302-07. http://www.ncbi.nlm.nih.gov/pubmed/7810561
Fryns JP, Haspeslagh M. Mental retardation, short stature, minor skeletal anomalies, craniofacial dysmorphism and macrodontia in two sisters and their mother. Another variant example of KBG syndrome? Clin Genet. 1984;26:69-72. http://www.ncbi.nlm.nih.gov/pubmed/6467660
Hermann J, Pallister PD, Tiddy W, Optiz JM. The KBG syndrome – a syndrome of short stature, characteristic facies, mental retardation, macrodontia and skeletal anomalies. Birth Defects. 1975;11:7-18. http://www.ncbi.nlm.nih.gov/pubmed/1218237
FROM THE INTERNET
McKusick VA., ed. Online Mendelian Inheritance in Man (OMIM). Baltimore. MD: The Johns Hopkins University; Entry No:148050; Last Update:11/09/2015. Available at: http://omim.org/entry/148050 Accessed: August 20, 2016.
Brancati F, Dallapiccola B, Sarkozy A. KBG Syndrome. Orphanet Encyclopedia, December 2006. Available at: http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Expert=2332 Accessed: August 20, 2016.
Genetics Home Reference. KBG Syndrome. August 23, 2016. Available at: https://ghr.nlm.nih.gov/condition/kbg-syndrome Accessed: August 20, 2016.
The information in NORD’s Rare Disease Database is for educational purposes only and is not intended to replace the advice of a physician or other qualified medical professional.
The content of the website and databases of the National Organization for Rare Disorders (NORD) is copyrighted and may not be reproduced, copied, downloaded or disseminated, in any way, for any commercial or public purpose, without prior written authorization and approval from NORD. Individuals may print one hard copy of an individual disease for personal use, provided that content is unmodified and includes NORD’s copyright.
National Organization for Rare Disorders (NORD)
55 Kenosia Ave., Danbury CT 06810 • (203)744-0100